Patient-Reported Outcomes During Checkpoint Inhibition: Insight into Symptom Burden in Daily Clinical Practice
Open Access
- 20 February 2022
- journal article
- research article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 63 (6) , 997-1005
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodiesAnnals of Oncology, 2015
- Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter studyCancer, 2015
- Bringing PROMIS to practice: Brief and precise symptom screening in ambulatory cancer careCancer, 2014
- Review of Electronic Patient-Reported Outcomes Systems Used in Cancer Clinical CareJournal of Oncology Practice, 2014
- What Is the Value of the Routine Use of Patient-Reported Outcome Measures Toward Improvement of Patient Outcomes, Processes of Care, and Health Service Outcomes in Cancer Care? A Systematic Review of Controlled TrialsJournal of Clinical Oncology, 2014
- A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic settingBMC Health Services Research, 2013
- Priorities of head and neck cancer patients: a patient survey based on the brief ICF core set for HNCEuropean Archives of Oto-Rhino-Laryngology, 2013
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant TumoursJournal of Thoracic Oncology, 2007
- Symptom Prevalence in Patients with Incurable Cancer: A Systematic ReviewJournal of Pain and Symptom Management, 2007